GENEQUALITY® 2050: Powering Fully Automated Molecular Diagnostics from Sample to Result | Webinar

Explore with us how next-generation automation is transforming molecular diagnostics, enabling more efficient workflows and reliable testing from sample to result.

Join our webinar to learn more about the GENEQUALITY^® 2050 system, its current assay portfolio, and future developments in diagnostic testing.

Agenda and key takeaways:

• Discover the GENEQUALITY^® 2050 real-time sample-to-result PCR platform featuring Computer Vision technology, designed to accelerate workflows and minimize errors.
• Get an overview of our current molecular diagnostics (MDx) assay portfolio.
• Learn about the roadmap for expanding the assay menu with new MDx diagnostic panels.